| Stereochemistry | MIXED |
| Molecular Formula | C23H40O6 |
| Molecular Weight | 412.5601 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(C)(OC)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
InChI
InChIKey=GGDWDKDPRJFMHD-ZXYUVVQBSA-N
InChI=1S/C23H40O6/c1-5-6-15-23(2,29-4)21(26)14-13-18-17(19(24)16-20(18)25)11-9-7-8-10-12-22(27)28-3/h13-14,17-18,20-21,25-26H,5-12,15-16H2,1-4H3/b14-13+/t17-,18-,20-,21-,23?/m1/s1
| Molecular Formula | C23H40O6 |
| Molecular Weight | 412.5601 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Mexiprostil (also known as MDL 646), a synthetic prostaglandin was developed as a potent antiulcer agent. Experiments on animals have revealed that this drug possessed gastric protection, diarrheogenic and arterial hypotensive effects. The supposed local activity coupled with the antisecretory effects and the good tolerability made it interesting to test mexiprostil as an anti-ulcer agent in man. However, information about the further development of the drug is not available.
